Company: PFSA
Filing Date: 2025-04-03
Form Type: S-4/A
Source: 0001213900-25-028544
Chunk: 318

Company: Profusa, Inc.
Filing Date: 2025-04-03
Form: S-4/A
Chunk 318
---
 the requisite time frame and force NorthView to liquidate. • Exclusivity.The fact that the Merger Agreement includes an exclusivity provision that prohibits NorthView from soliciting other business combination proposals, which restricts NorthView’s ability, so long as the Merger Agreement is in effect, to consider other potential business combinations. • Risks regarding the stockholder vote.The risk that NorthView’s stockholders may fail to provide the votes necessary to effect the Merger. • Closing conditions.The fact that completion of the Merger is conditioned on the satisfaction of certain closing conditions that are not within NorthView’s control, including approval by NorthView’s stockholders and approval by Nasdaq of the initial listing application in connection with the Merger. • Potential litigation.The possibility of litigation challenging the Merger or that an adverse judgment granting permanent injunctive relief could indefinitely enjoin consummation of the Merger. • Fees and expenses.The fees and expenses associated with completing the Merger. • Potential impacts of COVID -19 .Uncertainties regarding the potential impacts of the COVID -19virus and related economic disruptions on Profusa’s operations. • Other risk factors.Various other risk factors associated with the respective businesses of NorthView and Profusa as described in the section entitled “ Risk Factors” appearing elsewhere in this proxy statement/prospectus. We may complete the Business Combination only if it is approved by the affirmative vote of the members representing at least a simple majority of the votes cast by holders of NorthView Common Stock present and voting in person or by proxy at the special meeting of NorthView stockholders. The Business Combination is therefore not structured so that approval of at least a majority of unaffiliated NorthView Stockholders is required. No unaffiliated representative has been retained to act solely on behalf of the NorthView stockholders for purposes of negotiating the terms of the Merger Agreement on their behalf and/or preparing a report concerning the approval of the Business Combination. The Business Combination was unanimously approved by NorthView’s Board. The NorthView Board concluded that the potential benefits expected for NorthView and its stockholders as a result of the Merger outweighed the any potentially negative factors related to the Merger. Accordingly, the NorthView Board unanimously determined that the Merger Agreement, and the transactions contemplated thereby, including the Merger, were advisable, fair to and in the best interests of NorthView and its stockholders. 161 Profusa Reasons for the Merger In the course of reaching its decision to approve the merger, the Profusa board